Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cecchini

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Current Treatment Options in Oncology|July 30, 2020
Targeted Therapies in Advanced Gastric CancerTimil H Patel, Michael Cecchini
Journal for Immunotherapy of Cancer|March 26, 2015
Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplantMichael Cecchini, Mario Sznol, Stuart Seropian
Journal of Cutaneous Medicine and Surgery|February 1, 2013
Atypical presentation of congenital yellow nail syndrome in a 2-year-old femaleMichael Cecchini, Joseph Doumit, Nordau Kanigsberg
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
<i>EGFR</i> Exon 19 Deletion in Pancreatic Adenocarcinoma Responds to Erlotinib, Followed by <i>T790M</i>-Mediated ResistanceMichael Cecchini, Jeffrey Sklar, Jill Lacy
Blood|January 27, 2016
The implementation of electronic hematology consults at a VA hospitalMichael Cecchini, Michal G Rose, Ellice Y Wong, et al.
Journal of Oncology Practice|September 22, 2016
Electronic Intervention to Improve Structured Cancer Stage Data CaptureMichael Cecchini, Kim Framski, Patricia Lazette, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 2, 2021
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer DatabaseJohannes Uhlig, Michael Cecchini, Amar Sheth, et al.
Abdominal Radiology (New York)|September 24, 2021
Can a simplified CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection?Yang Guo, Ferenc Czeyda-Pommersheim, Joseph A Miccio, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Clinical outcomes of first line FOLFIRINOX <i>vs.</i> gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital SystemTimil Patel, Joseph Miccio, Michael Cecchini, et al.
Scientific Reports|December 17, 2024
Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasmsJohannes Uhlig, James Nie, Joanna Gibson, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Current Treatment Options in Oncology|July 30, 2020
Targeted Therapies in Advanced Gastric CancerTimil H Patel, Michael Cecchini
Journal for Immunotherapy of Cancer|March 26, 2015
Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplantMichael Cecchini, Mario Sznol, Stuart Seropian
Journal of Cutaneous Medicine and Surgery|February 1, 2013
Atypical presentation of congenital yellow nail syndrome in a 2-year-old femaleMichael Cecchini, Joseph Doumit, Nordau Kanigsberg
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
<i>EGFR</i> Exon 19 Deletion in Pancreatic Adenocarcinoma Responds to Erlotinib, Followed by <i>T790M</i>-Mediated ResistanceMichael Cecchini, Jeffrey Sklar, Jill Lacy
Blood|January 27, 2016
The implementation of electronic hematology consults at a VA hospitalMichael Cecchini, Michal G Rose, Ellice Y Wong, et al.
Journal of Oncology Practice|September 22, 2016
Electronic Intervention to Improve Structured Cancer Stage Data CaptureMichael Cecchini, Kim Framski, Patricia Lazette, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 2, 2021
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer DatabaseJohannes Uhlig, Michael Cecchini, Amar Sheth, et al.
Abdominal Radiology (New York)|September 24, 2021
Can a simplified CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection?Yang Guo, Ferenc Czeyda-Pommersheim, Joseph A Miccio, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Clinical outcomes of first line FOLFIRINOX <i>vs.</i> gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital SystemTimil Patel, Joseph Miccio, Michael Cecchini, et al.
Scientific Reports|December 17, 2024
Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasmsJohannes Uhlig, James Nie, Joanna Gibson, et al.
Pageof 7